BIRC2 and hepatocellular carcinoma: Consistently, DNA amplifications of Birc2 and Birc3 have been observed in mouse liver and human lung cancers [24,25], liver carcinoma [24], oral squamous cell carcinoma [26,27], medulloblastoma [28], glioblastoma [29], and pancreatic cancer [30].